SpiroChem is pleased to announce its participation in RESI Boston 2026, taking place on September 22–23, 2026 as part of Biotech Week Boston.
RESI is a partnering-focused conference bringing together early-stage life science companies, investors, corporate partners and business development professionals. The program is designed to support one-to-one meetings, fundraising discussions and strategic connections across the biotech and healthcare ecosystem.
Through its combination of partnering, investor sessions and networking opportunities, the conference provides a platform for companies to explore new collaborations, identify potential partners and engage with stakeholders across the life sciences sector.
Meet our team on-site:
Thomas Fessard, PhD – CEO
Connect with us during the conference to discuss potential collaborations and learn more about SpiroChem’s capabilities in discovery chemistry and early-stage drug discovery.
We look forward to engaging with companies, investors and strategic partners and to exploring new opportunities for collaboration.
